WeightWatchers’ Post

Time Restricted Feeding: A Review 🍽️ Head over to the ACOFP Voice to read about the lifestyle aspect of treating obesity, specifically the effects of intermittent fasting, in the words of Dr. Ann D. Glassman. This paper was submitted with her application for ACOFP Fellowship. Read the paper: https://ow.ly/HrMM50U4GHr

Recently, a cardiologist reader, with an open mind exploring the health benefits of fasting for cardiovascular situations, wanted me to uncover clinical studies to support these claims. I am fully committed to honoring this request and shedding light on the evidence behind time-restricted eating. Despite my three-decade journey following literature on fasting, intermittent fasting has only truly gained the spotlight in the last decade. Its rapid adoption by health and fitness communities has piqued the interest of scientists and clinicians, leading to an extensive investigation into its potential benefits, which I will summarize in this post in simple language. With the literature evolving rapidly, I am grateful that a dedicated group of researchers took on the challenge and conducted a thorough meta-analysis, compiling all significant papers and 133 clinical trials. Their findings were published in the prestigious Lancet’s eClinical Medicine journal on March 11, 2024, providing valuable insights into the field. They added this valuable paper to their collections in Nutrition & Metabolism, Global Health, Cardiology & Vascular Medicine, and Endocrinology, which are excellent knowledge repositories for scientists, clinicians, and interested readers. In this story, I aim to break down the key points of this remarkable study published in Lancet in March 2024. I summarize the reasons behind their research, how they conducted it, what they discovered, and what it all means to the public. Their findings shed light on important aspects of intermittent fasting, so I explain them in a way that is easy for anyone to grasp. You can read this important article using my friend link on Medium. https://lnkd.in/gpcPxgXd

For so long, many patients living with obesity have faced stigma. Today, breakthrough therapies are shifting perspectives, recognizing obesity as a treatable disease. We are thrilled to be joined by Joe Nadglowski, CEO of the Obesity Action Coalition, Dr. Robyn Pashby, Director of Health Psychology Partners, and moderator Karen Campbell of WTHR-TV, at the upcoming BioCrossroads Life Sciences Summit, for a fireside chat focusing on making strides in combating #stigma and #bias, and the ongoing efforts to #advocate for patients. #indiana #lifesciences #healthcare #IN #BioXSummit24

Obesity is both a personal health challenge and a societal issue that profoundly impacts communities. Beyond increasing individual risks of hypertension, diabetes, and heart disease, obesity contributes to broader social implications, including mental health challenges and economic burdens. At the upcoming BioCrossroads Life Sciences Summit, Dr. David Allison, Dean of the Indiana University School of Public Health-Bloomington, Dr. Virginia Caine, Director and Chief Medical Officer at the Marion County Health Department, and Indiana Health Commissioner Dr. Lindsay Weaver, will take part in a discussion surrounding the complex impacts of obesity, and strategies for addressing these challenges in our communities. #indiana #lifesciences #healthcare #IN #BioXSummit24

On World Health Day, we’d like to shine a spotlight on the Shoppers Drug Mart team who attended the Obesity + Hypertension in Canada Conference earlier this week. Here, Aarti Patel, PharmD, RPh, Amir Naseri, Lori LeBlanc and Chris Potter presented the findings of a 13-week study funded by our organization. The study was conducted with the support of over 40 Shoppers’ locations across Canada, exploring the role community pharmacists can play in screening for chronic diseases such as diabetes.    It found that 42% of participants had moderate or high risk for a cardiovascular event in the next 10 years. Furthermore, almost 20% of participants were found to have HbA1C values consistent with prediabetes or diabetes.     We know that early intervention for chronic disease can save lives. It can also reduce burdens on an already strained healthcare system. Among its findings, the report highlights a desperate need for these vital services, but also a pharmacist’s ability to deliver them effectively.    For more on the findings of this study, check out the Community Pharmacies as Catalysts for Change: The Role of Pharmacists in Screening and Initiating Early Interventions for Chronic Diseases video on the Obesity Canada website: https://bit.ly/4alvt7K #sciencetosolutions #worldhealthday #hearthealth #communitypharmacist #chronicdiseasemanagement

Want to see how using Atropos Health can help accelerate your clinical research? Reach out today and I’ll show you how we can expedite your research project from question formation through manuscript submission in a matter of weeks rather than months or years!

On behalf of my co-authors and collaborators, I'm very excited to share that our landmark Gastric Fundus Mucosal Ablation study is now published in Gastroenterology. This first-in-human study showed that endoscopic hybridAPC of the gastric fundus led to a significant decrease in fasting plasma ghrelin, hunger, meal capacity, and weight. This is the first study to demonstrate the potential of gastric mucosal ablation as a treatment for adults with obesity. With numerous ongoing and planned studies, we are committed to further evaluating these techniques as primary and secondary therapies for obesity. The need for safe, efficient, and effective tools to address the pressing global obesity epidemic has never been more urgent. American Gastroenterological Association (AGA) Erbe Elektromedizin GmbH Vivek Kumbhari MD PhD Daniel Maselli, M.D. Lauren Donnangelo, MD, D-ABOM Christopher Chapman Dilhana Sumaiya Badurdeen #Gastroenterology #Research #WeightLoss #MetabolicHealth #Innovation #TrueYouWeightLoss #GFMA #Healthcare #Obesity

In the spirit of Heritage 🇿🇦 , we honour three doctors who dedicated themselves to evidence-based medicine, often at great expense to their personal and professional lives. They put science and patients first, rather than dogma and commercial interest. Dr Robert Atkins was a cardiologist who treated tens of thousands of patients successfully with diet and lifestyle, starting in the 1970s. Dr John Yudkin, a remarkable scientist, wrote a book in 1972 called Pure, White And Deadly, which correctly predicted the obesity and metabolic disease epidemic to come. And, Dr Sarah Hallberg, who ignored the established dietary guidelines and pioneered a therapeutic diet to reverse type 2 diabetes. In our own small way, we are dedicated to helping people get healthier, based on science. REVIVE Daily Electrolytes is not just a performance product. It is formulated to help people succeed with their journey to health, whether through fasting, eating better, healthier breast-feeding, overcoming cancer or running marathons. Sign up to our mailing list today and be first in line for exciting updates, the latest scoop, industry news, and exclusive access to offers and deals 👉  https://lnkd.in/dNvGeUAP

The Obesity Medicine Association's Committee Chairs have made some exciting predictions about advancements and challenges in #obesity medicine over the next five years. As an advocate for comprehensive patient care, I'm glad to see the focus on biology, education, and legislation rather than behavior change. Some key predictions include integrating obesity treatment into medical school curricula by 2029, the recognition of Obesity Medicine as a subspecialty, the increased use of advanced medications, and improved insurance and treatment accessibility. Digbi Health is committed to supporting these advancements through our innovative "Food Is Medicine" approach and our GLP Compass (tm) tool, which is designed to identify the most effective treatment pathways for individual patients based on their biology- #genetics and #gutmicrobiome We are excited to contribute to and witness the next leaps in obesity medicine. For a deeper dive into these fascinating predictions and to understand where the field is headed, check out the full article here. https://lnkd.in/g6f3n9-r? Chantell Reagan Louise Short, MD, MSc, FACOEM Ronesh Sinha Mamata Majmundar, MD, FAAFP, CPE WTW Lockton Health Transformation Alliance Virgin Pulse Solera Health Justin Larkin, MD Byron Crowe

We are again highlighted in Forbes. The author, Rob Kniaz, summarizes his view on the incredible possibilities of phages for global health, and we definitely agree: “Over the coming decade I find this area to be one of the more interesting opportunity areas in biology as the sector is more heavily explored and initial human applications are expanded, particularly around things like digestive disorders such as Crohn’s Disease. If companies are able to derive IP protection through novel synthesis of numerous phages, this area could be poised for very rapid growth as the failure of antibiotics forces new thinking amongst clinicians.” Read the piece here: https://lnkd.in/ebrMBaJv #ScienceWorks #Phages